Literature DB >> 28358730

Individualized antiretroviral therapeutic approaches: less can be more.

Christine Katlama1, Jade Ghosn, Robert L Murphy.   

Abstract

Mesh：

Substances：

Year:  2017        PMID： 28358730     DOI： 10.1097/QAD.0000000000001476

Source DB:  PubMed          Journal:  AIDS        ISSN： 0269-9370            Impact factor:   4.177


× No keyword cloud information.
  4 in total

1.  Electronic Dose Monitoring Identifies a High-Risk Subpopulation in the Treatment of Drug-resistant Tuberculosis and Human Immunodeficiency Virus.

Authors:  Jennifer R Zelnick; Amrita Daftary; Christina Hwang; Amy S Labar; Resha Boodhram; Bhavna Maharaj; Allison K Wolf; Shinjini Mondal; K Rivet Amico; Catherine Orrell; Boitumelo Seepamore; Gerald Friedland; Nesri Padayatchi; Max R O'Donnell
Journal:  Clin Infect Dis       Date:  2021-10-05       Impact factor: 9.079

2.  Real-World Experience with Dolutegravir-Based Two-Drug Regimens.

Authors:  Douglas Ward; Moti Ramgopal; David J Riedel; Cindy Garris; Shelly Dhir; John Waller; Jenna Roberts; Katie Mycock; Alan Oglesby; Bonnie Collins; Megan Dominguez; James Pike; Joseph Mrus
Journal:  AIDS Res Treat       Date:  2020-07-07

3.  Comparative efficacy and safety and dolutegravir and lamivudine in treatment naive HIV patients.

Authors:  Matthew Radford; Daniel C Parks; Shannon Ferrante; Yogesh Punekar
Journal:  AIDS       Date:  2019-09-01       Impact factor: 4.177

4.  Costs and mortality associated with HIV: a machine learning analysis of the French national health insurance database.

Authors:  Martin Prodel; Laurent Finkielsztejn; Laëtitia Roustand; Gaëlle Nachbaur; Lucie De Leotoing; Marie Genreau; Fabrice Bonnet; Jade Ghosn
Journal:  J Public Health Res       Date:  2021-11-29
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.